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INTRODUCTION 
 
Aging is a major cardiovascular risk factor [1]. 
Cardiomyocyte apoptosis increases during aging, which 
in turn has been shown to be related to decreased 
cardiac reserve [2] and increased sensitivity to ischemia 
reperfusion injury [3], stress overload, and other 
cardiovascular diseases [4]. Studies have shown that  
 
mitochondria play an important role in regulating 
apoptosis during aging [5]. However, the molecular 
mechanism of mitochondrial-mediated apoptosis in the 
aging heart remains unclear. 
 
Omi/HtrA2 is a pro-apoptotic protein located in the 
mitochondria, which is released into the cytoplasm after 
an apoptotic stimulus [6], initiating apoptosis [7]. Our 
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ABSTRACT 
 
Background: Increased cardiac apoptosis is a hallmark of the elderly, which in turn increases the risk for 
developing cardiac disease. The overexpression of Omi/HtrA2 mRNA and protein contributes to apoptosis in the 
aged heart. Heat shock factor 1 (HSF1) is a transcription factor that binds to the promoter of Omi/HtrA2 in the 
aging myocardium. However, whether HSF1 participates in cardiomyocyte apoptosis via transcriptional regulation 
of Omi/HtrA2 remains unclear. The present study was designed to investigate whether HSF1 plays a role in 
Omi/HtrA2 transcriptional regulation and myocardial apoptosis. 
Methods and Results: Assessment of the hearts of mice of different ages was performed, which indicated a 
decrease in cardiac function reserve and an increase in mitochondrial apoptosis. Omi/HtrA2 overexpression in the 
elderly was negatively correlated with left ventricular function after exercise overload and positively correlated 
with myocardial Caspase-9 apoptosis. Chromatin immunoprecipitation (ChIP) of aging hearts and plasmid 
transfection/RNA interference of H9C2 cells revealed that enhancement of HSF1 expression promotes Omi/HtrA2 
expression by inducing the promoter activity of Omi/HtrA2 while also increasing mitochondrial apoptosis by 
upregulating Omi/HtrA2 expression. 
Conclusions: HSF1 acts as a transcriptional factor that induces Omi/HtrA2 expression and Caspase-9 apoptosis in 
aged cardiomyocytes, while also decreasing cardiac function reserve. 
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preliminary study found that Omi/HtrA2 is released 
from the mitochondria and into the cytoplasm during 
myocardial ischemia-reperfusion (I/R) injury in rats, 
which in turn increases ischemia-reperfusion injury [8]. 
 
Our preliminary study found increased Omi/HtrA2 
mRNA and protein expression in the myocardium of 
aging rats, aggravating I/R injury by inducing the 
apoptosis of myocardial cell [9]. Cardiac-specific 
overexpression of mitochondrial Omi/HtrA2 promotes 
cardiomyocyte apoptosis and heart dysfunction [10], 
activates Caspases, and disrupts mitochondrial 
homeostasis in the aged heart [11]. However, the 
regulatory mechanism of Omi/HtrA2 in aged myocardial 
tissues remains elusive. 
 
Further investigation of the mechanism of increased 
Omi/HtrA2 using a luciferase reporter assay indicated 
that the Omi/HtrA2 promoter core regions are situated 
within -1,205 to -838 bp and -146 to +93 bp. 
Furthermore, we confirmed that Heat shock factor 1 
(HSF1) can bind to the Omi/HtrA2 promoter in the 
myocardium as a transcription factor [12]. These 
findings suggest that HSF1 is an important 
transcriptional factor that is involved in regulating 
Omi/HtrA2 mRNA levels. However, the role and 
expression of HSF1 and whether it regulates 
Omi/HtrA2 in the aging heart remain elusive. 
 
In this study, we evaluated cardiac reserve and cardiac 
myocyte apoptosis in the aging mouse. We report that 
the overexpressing of the transcription factor HSF1 in 
cardiomyocytes up-regulates Omi/HtrA2 expression and 
contributes to mitochondrial apoptosis in aged cardiac 
myocytes. Our study investigated the regulatory 
mechanism of Omi/HtrA2 expression by HSF1 in the 
aging heart, and it provides a novel theory of HSF1 in 
myocardial apoptosis. 
 
RESULTS 
 
Cardiac reserve decreases in aged mice 
 
The mouse aging model was constructed using four 
groups of mice based on ages: 4 months (young group), 
12 months (middle age group), 18 months (presenium 
group), and 24 months (aging group) [13] and evaluated 
using different classic aging indexes: the mRNA and 
protein levels of aging-associated proteins p16, p53, and 
β-galactosidase The results showed that the mRNA 
levels of p16 and p53 increased with age (see 
Supplementary Figure 1A and 1B),. The protein levels 
of p16, p53, and β-galactosidase also increased with age 
(see Supplementary Figure 1C–1F). Mice 18 months 
and older showed poor in illustriousness and mobility, 
particularly those of age 24 months. Most of the mice 
with ages above 18 months had developed hearing loss. 
These findings supported that the mice used in this 
study were adequately grouped to simulate the process 
of physiological aging. 
 
To determine whether cardiac reserve had changed in 
aging mice, echocardiography was performed at different 
ages (4 months, 12 months, 18 months, and 24 months 
old). In our study, ejection fraction (EF) and fractional 
shortening (FS) reflected cardiac systolic function, and 
E/A ratio was tested for diastolic function. No significant 
differences were observed in EF, left ventricular FS, and 
E/A ratio at rest. However, after exercise load, the EF 
(Figure 1A and 1B), FS (Figure 1A and 1C) of the 24-
month-old groups decreased compared to the 4-month-
old group, and the E/A ratio (Figure 1A and 1D) of the 
18- and 24-month-old groups decreased compared to the 
4-month-old group, suggesting a decrease in the cardiac 
reserve of the aged group. Simultaneously, the results of 
echocardiography showed that the left ventricular end-
diastolic diameter (LVID(d)) increased (Figure 1E), the 
left ventricular posterior wall end-diastolic thickness 
(LVPW(d)) increased (Figure 1F), and the mass of the 
left ventricle (LV mass) increased (Figure 1G) with 
aging. These findings were suggestive of left ventricular 
hypertrophy. We also measured the ratio of the heart 
weight to total weight to observe changes in the aging 
heart, which showed that the ratio decreased with age 
(Figure 1H). We measured the systolic blood pressure to 
evaluate changes in vascular function and found that the 
systolic blood pressure of the mice did not significantly 
change with age (Supplementary Figure 2). We also 
evaluated the levels of atherogenic process in aorta, there 
were no distinctly different pathological changes in aorta 
of aged rats by HE staining, Masson trichrome stain and 
sirus red stain (Supplementary Figure 3A–3C), however. 
To evaluate thoracic aorta endarterium morphology, 
thoracic aorta endothelium biomarkers CD31 was 
detected by immunohistochemical stain (IHC). It showed 
that the damage of intimal layer continuity, loss of some 
vascular endothelial cells, shallow staining, and enlarged 
junction space in aging (Supplementary Figure 3D). It 
dedicated that the endothelium injury in aged aorta. 
 
The rate of apoptosis of cardiomyocytes increases in 
aged mice via the mitochondrial apoptotic pathway 
and is negatively correlated to cardiac systolic 
function 
 
Reduction of antioxidation ability and increasing 
oxidative stress occurred in aged heart. Levels of 
antioxidants showed that total antioxidant activity (T-
AOC) decreased (Supplementary Figure 4A), SOD 
activity decreased with age (see Supplementary Figure 
4B), and malondialdehyde (MDA) increased 
(Supplementary Figure 4C) in aged myocytes. The 
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production of ROS in general and mitochondrial in 
particular was increased (Supplementary Figure 4D, 4E) 
in aging heart compared with 4 month old mice. The 
level of ATP in aging myocardium was decreased 
(Supplementary Figure 4F). 
 
To evaluate the relevance of cardiomyocyte apoptosis 
and decreased cardiac reserve in aged mice, 
cardiomyocyte apoptosis in mice from different age 
groups was assessed by TUNEL staining myocardial 
tissue sections and determination of Caspase activity. 
The results demonstrated that the number TUNEL-
positive cells increased with age (Figure 2A). In 
addition, Caspase-3 activity (a critical effector Caspase) 
in mouse cardiomyocytes also increased with age 
(Figure 2B). Caspase-9 activity (an initiator Caspase in 
the mitochondrial pathway) significantly increased in 
the older groups (18 and 24 months) (Figure 2C). 
However, Caspase-8 activity (an initiator Caspase of the 
extrinsic pathway) (Figure 2D) and Caspase-12 activity 
(an endoplasmic reticulum-specific stress-activated 
Caspase pathway) (Figure 2E) did not change. These 
results indicated that mitochondrial apoptosis is the 
main pathway in the aged heart. Caspase-9 activity was 
negatively correlated with left cardiac systolic function 
(EF, FS) after exercise (Figure 2F and 2G). However, 
there was also no correlation between Caspase-9 and 
diastolic function (Supplementary Figure 5). 
 
 
 
Figure 1. The cardiac reserve function decreases in aging mice. Echocardiography of the mice (A). Eject factor (EF, %) (B). Fractional 
shortening (FS, %) (C). The ratio of the early to late ventricular filling velocities (E/A ratio) (D). Left ventricular end-diastolic diameter (LVID(d), 
mm) (E). Left ventricular posterior wall end-diastolic thickness (LVPW(d), mm) (F). Left ventricular mass (LV mass, mg) (G). The ratio of the 
heart weight to total weight (H). Data are represented as mean +/- SEM. n = 6 per group. *P<0.05, **P<0.01 vs. 4 m. m=month.  
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The upregulation of Omi/HtrA2 in aging 
myocardium is negatively correlated with the decline 
in left ventricular function and the ratio of heart 
weight to total weight 
 
To determine the expression of Omi/HtrA2 (a pro-
apoptotic protein) in the aging heart, we detected its 
mRNA and protein levels by RT-qPCR and western blot 
analyses. The results showed that the mRNA and protein 
levels of Omi/HtrA2 significantly increased in the 
presenium group (18 months) and the older group (24 
months) compared to the young group (Figure 3A and 
3B). To evaluate the mRNA levels of Omi/HtrA2 and 
cardiac function in aging mice, we analyzed the 
correlation in the mRNA levels of Omi/HtrA2 as well as 
in the EF, FS, and diastolic index. The results showed that 
the mRNA levels of Omi/HtrA2 were negatively 
correlated with left ventricular systolic function (Figure 
3C and 3D), but had no significant correlation with 
diastolic function (Figure 3E). We also analyzed 
Omi/HtrA2 mRNA, LVID(d), LVPW(d), and LV mass to 
explore the correlation between Omi/HtrA2 mRNA level 
and cardiac structure in aging mice, in which we found no 
significant correlation (Figure 3F–3H). However, the 
mRNA level of Omi/HtrA2 was negatively correlated 
with the ratio of heart weight to total weight (Figure 3I). 
 
 
 
Figure 2. Aging mice exhibit higher cardiomyocytes apoptotic rates and Caspase-9 activity but lower cardiac systolic 
function. TUNEL labeling and apoptotic index of paraffin-embedded cardiac tissues (A). Evaluation of Caspase-3, Caspase-9, Caspase-8, 
Caspase-12 activity in mice of different ages (B–E), data are represented as mean +/- SEM. n = 6 per group. *P<0.05, **P<0.01 vs. 4m. 
m=month. The correlation analysis between the expression of Caspase- 9 activity and ejection fraction (EF, %) (F). The correlation analysis 
between the Caspase -9 activity and fractional shortening (FS, %) (G). n=32. 
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Overexpression of HSF1 in myocardium promotes 
Omi/HtrA2 mRNA and protein expression by 
enhancing the promoter activity of Omi/HtrA2 
 
HSF1 is a critical transcriptional factor correlated with 
chronic stresses and heart disease [14]. To investigate 
changes in HSF1 in the aging heart, HSF1 expression 
was detected by western blot analysis of heart tissues. 
High levels of the HSF1 protein were detected in the 
aged cardiac myocytes (Figure 4A). In our previous 
study, we found that HSF1 binds to the Omi/HtrA2 
promoter as a transcription factor. To determine whether 
increased HSF1 is involved in Omi/HtrA2 expression, we 
detected the nucleoprotein in cardiomyocytes and also 
assessed changes in the binding ability of HSF1 to the 
promoter by ChIP. An increase in HSF1 levels in the 
nucleus was observed (Figure 4B), as well as binding to 
the Omi/HtrA2 promoter were observed in the aged heart 
(Figure 4C). To gain a deeper understanding of the 
mechanism involved in HSF1-based regulation of 
Omi/HtrA2, HSF1-overexpressing NIH3T3 cells were 
prepared by transiently transfecting pcDNA3.1-HSF1 
 
 
 
Figure 3. Correlation analysis of Omi/HtrA2 mRNA expression and cardiac reserve function with aging. The mRNA levels of 
Omi/HtrA2 were assessed by quantitative RT-PCR (A). Protein expression was evaluated by western blotting (B). Data are represented as 
mean +/- SEM, n = 6 per group. *P<0.05, **P<0.01 vs. 4m. m=month. A strong negative correlation between Omi/HtrA2 mRNA expression 
and ejection fraction (EF, %) was observed with aging (C). A significant linear negative correlation between Omi/HtrA2 mRNA expression and 
fractional shortening (FS, %) with aging (D). No significant linear correlation between Omi/HtrA2mRNA expression and E/A ratio (E). No 
significant linear correlation between Omi/HtrA2 mRNA levels and left ventricular end-systolic diameter (LVID, mm) was observed (F). The 
correlation analysis between Omi/HtrA2 mRNA levels and left ventricular posterior wall end-systolic thickness (LVPW, mm) (G). Correlation 
analysis between Omi/HtrA2 mRNA levels and left ventricular mass (LV mass, mg) (H). A significant linear negative correlation between 
Omi/HtrA2 mRNA expression and heart/body weight with aging (I).  
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(Figure 4D). HSF1 protein in the nucleus was regulated 
in the transfected NIH3T3 cells (Figure 4E). 
Overexpression of HSF1 increased the mRNA and 
protein levels of Omi/HtrA2 (Figure 4F and 4G), and the 
activity of the Omi/HtrA2 promoter was enhanced 
(Figure 4H). 
 
To further confirm that HSF1 regulates Omi/HtrA2 
expression through transcription activation, we detected 
the activity of the Omi/HtrA2 promoter after RNA 
interference of HSF1. The introduction of small 
interfering RNA (siRNA) resulted in the inhibition of 
HSF1 expression in the NIH3T3 cells (Figure 4I). The 
HSF1 nucleoprotein was downregulated (Figure 4J). 
Knocking down HSF1 resulted in a reduction in the 
activity of the Omi/HtrA2 promoter (Figure 4K), as 
well as the mRNA (Figure 4L) and protein levels of 
Omi/HtrA2 (Figure 4M). 
 
 
 
Figure 4. Overexpression of HSF1 in the myocardium promotes the expression of Omi mRNA and protein levels by enhancing 
the activity of the promoter of Omi/HtrA2. Total and nucleoprotein HSF1 expression was increased in aging myocardium, GAPDH, and 
histone H3 as internal control (A, B). Data are represented as mean +/- SEM. **P< 0.01 vs. young, n = 6 per group. The binding of HSF1 to the 
Omi/HtrA2 promoter increased in aging mice (C). Total and nucleoprotein HSF1 expression increased after transient transfection of 
pcDNA3.1-HSF1 (D, E). mRNA and protein levels of Omi/HtrA2 increased after transient transfection of pcDNA3.1-HSF1 (F, G). Relative 
luciferase activity of PGL-239 increased after transient transfection of pcDNA3.1-HSF1 (H). Values are means ± SEM, *P<0.05, **P<0.01 vs. 
pcDNA3.1, n = 3. Total and nucleoprotein HSF1 expression decreased after transient transfection of siRNA-HSF1 (I, J). Relative luciferase 
activity of PGL-239 decreased after transient transfection of siRNA -HSF1 (K). mRNA and protein levels of Omi/HtrA2 increased after transient 
transfection of pcDNA3.1-HSF1 (L, M), Values are means ± SEM, #P<0.05, ##P<0.01 vs. scramble, n = 3. 
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Overexpression of HSF1 induces mitochondria 
apoptosis by regulating Omi/HtrA2 expression in 
H9C2 cells 
 
To determine the effects of HSF1 on Omi/HtrA2-
mediated apoptosis in cardiomyocyte, we upregulated 
HSF1 by transiently transfecting the pcDNA3.1-HSF1 
plasmid into cultured H9C2 cells, and HSF1 had no 
change after knockdown Omi/HtrA2 by RNA 
interference compared to that in the HSF1+scramble 
group (Figure 5A and 5B). Omi/HtrA2 expression 
increased in the pcDNA3.1-HSF1 group. Then, 
Omi/HtrA2 expression was silenced by RNA interference 
compared to that in the HSF1+scramble group (Figure 
5A and 5C). 
 
We demonstrated that Caspase-9 activity increased in the 
pcDNA3.1-HSF1 group, and the effect was suppressed 
by siRNA Omi/HtrA2 (Figure 5D). In addition, Caspase-
3 activity was retained in the pcDNA3.1-HSF1 group, 
and similar change was observed after transfecting 
siRNA Omi/HtrA2 (Figure 5E). 
 
 
 
Figure 5. Overexpression of HSF1 participates in mitochondrial apoptosis by regulating Omi/HtrA2 expression in H9C2 cells. 
HSF1 expression increased after transfection of plasmid pcDNA3.1, which was not affected by RNAi Omi/HtrA2 (A, B). Omi/HtrA2 protein 
expression increased after transfection of plasmid pcDNA3.1, which decreased after RNAi Omi/HtrA2 (A, C). Caspase -9 activity was induced 
by HSF1 overexpression, which was reversed after transient transfection of si-Omi/HtrA2 (D). Caspase-3 activity was suppressed by HSF1 
overexpression, but similar change was detected after RNAi using Omi/HtrA2 (E). Data are represented as mean +/- SEM. *P<0.05, **P<0.01 
vs. pcDNA3.1, #P<0.05, ##P<0.01 vs. HSF1+scramble, n = 4. 
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DISCUSSION 
 
The present study describes the novel roles of HSF1 in 
regulating the pro-apoptosis protein Omi/HtrA2 in aged 
cardiomyocytes, which include the following: (i) using 
cardiac tissue, we demonstrated that HSF1 protein as 
well as its level in the nucleus were increased in the 
aged heart; (ii) overexpression of HSF1 induces 
 
Omi/HtrA2 expression by enhancing the promoter  
activity of Omi/HtrA2 in aged cardiomyocytes; (iii) 
overexpression of HSF1 enhances mitochondria apoptosis 
by upregulating Omi/HtrA2 in vivo. Taken together, these 
results indicate that HSF1 as a transcriptional factor 
participates in myocardial mitochondria apoptosis by 
enhancing the promoter activity of the pro-apoptosis gene 
Omi/HtrA2 in aged cardiomyocytes. 
 
Aging is a vital risk factor that increases the risk of 
developing cardiovascular decrease. A decrease in cardiac 
reserve [15], high sensitivity to ischemia reperfusion injury 
[16], and stress load [17], are characteristics of the elderly 
that reduce the quality of life. Cardiomyocyte apoptosis 
increases the risk of cardiovascular disease in the aged 
heart [13]. In this study, four groups of mice of different 
ages were used to simulate the process of physiological 
aging. We demonstrated that cardiac functional reserve 
decreased in the aged group after exercise, whereas no 
significant change was observed at the resting state. Aorta 
endothelium damaged in aged mice. Oxidant/antioxidant 
imbalance was more pronounced, In particular, 
mitochondrial oxidative stress increased. Apoptosis 
increased mainly via the mitochondrial pathway and was 
correlated to cardiac functional reserve, particularly the left 
heart diastolic function. These findings indicate that 
mitochondrial pathway apoptosis contributes to deficient 
cardiac functional reserve. 
 
Several studies have indicated that the mitochondria-
dependent apoptosis signaling pathway is more active in 
multiple organs of the elderly, for instance, muscle [18], 
heart [19]. Our previous study showed that the 
increased expression of Omi (also known as HtrA2) 
enhances MI/R injury in aged hearts [9] by inducing 
myocardial mitochondrial apoptosis [11]. 
 
Omi/HtrA2 is a serine protease located in the eukaryotic 
mitochondria, belonging to the high temperature 
requirement (HtrA) family. Studies have shown that mice 
with the motor neuron degeneration 2 (mnd2) mutation 
[20] and mice with Omi/HtrA2 knockout [21] exhibit a 
premature phenotype, which include osteoporosis, 
muscle atrophy, cardiac enlargement, and shortened life 
expectancy. Kang et al. reported that Omi/HtrA2 can 
regulate the protein quality of the mitochondrial 
intermembrane space [22], which is important for 
maintaining mitochondrial homeostasis. Disruption of 
mitochondrial homeostasis may be the reason for 
neurodegenerative disorders and premature senescence in 
non-nerve tissues [23]. 
 
In this study, we found that Omi/HtrA2 mRNA and 
protein levels increased in the presenium, with an even 
greater increase in the elderly group compared to the 
young group. The results were consistent with that of 
Caspase-9 activity. We also observed that the mRNA 
level of Omi/HtrA2 was negatively correlated with left 
ventricular systolic function after exercise and the ratio of 
heart weight to total weight. This study supported our 
previous findings that Omi/HtrA2 mRNA and protein 
levels increased with age and suggest that alterations in 
Omi/HtrA2 transcription and protein levels are closely 
associated with cardiac reserve by inducing 
mitochondrial pathway apoptosis. However, the 
regulatory mechanism of Omi/HtrA2 transcription in the 
aged heart remains elusive. 
 
Many factors impact on the expression of Omi/HtrA2. 
Prior study showed that hypoxia-inducible factor (HIF)-
1alpha inhibits Omi/HtrA2 expression and suppresses 
hepatocellular carcinoma cell apoptosis [7]. We 
previously confirmed that HSF1 can bind to the 
promoter region of Omi/HtrA2 in the myocardium by 
ChIP assay. This study confirmed that HSF1 as a 
transcription factor can regulate Omi/HtrA2 expression 
by showing that the nucleoprotein expression of HSF1 
in the aging myocardium increased, along with the 
binding to the Omi/HtrA2 promoter. We also confirmed 
that overexpressed HSF1 can increase Omi/HtrA2 
mRNA and protein levels by enhancing the activity of 
the Omi/HtrA2 promoter. These findings suggest that 
the activation of Omi/HtrA2 by HSF1 may be one of the 
mechanisms of Omi/HtrA2 overexpression in the aged 
myocardium. 
 
HSF1 is a major factor in regulating the expression of 
heat shock proteins, plays an important role in 
maintaining the accurate folding of proteins [14] and 
cellular homeostasis [24], and participates in cellular 
processes such as the stress response, aging, and 
carcinogenesis [14]. HSF1 performs very important 
functions in cardiovascular disease. HSF1 protects 
cardiomyocyte from I/R injury [25] and HSF1 
phosphorylation, which is activated by angiotensin II 
(ANG II), resulting in cardiac hypertrophy [26]. 
Furthermore, ANG II promotes insulin-like growth factor 
II receptor (IGF-IIR) expression and cardiomyocyte 
apoptosis by inhibiting HSF1 via c-Jun N-terminal kinase 
(JNK) activation and sirtuin 1 (SIRT1) degradation [27]. 
HSF1 expression increases in muscle tissue during aging 
[28]; however, HSF1-controlled chaperone capacity is 
suppressed in aged muscle cells [29]. This suggests that 
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HSF1 has a negative effect during aging. We have shown 
that HSF1 as a transcription factor of Omi/HtrA2 
enhances pro-apoptotic Omi/HtrA2 expression, thereby 
inducing cardiomyocyte apoptosis. HSF1 inhibits 
cardiomyocyte apoptosis but enhances mitochondrial 
apoptosis by upregulating Omi/HtrA2 expression. 
 
In summary, HSF1 enhances cardiomyocyte 
mitochondria -mediated apoptosis by activating 
Omi/HtrA2 transcription, and Omi/HtrA2 expression 
influences the cardiac function reserve of the aging heart. 
 
MATERIALS AND METHODS 
 
Animals 
 
The C57BL/6 male mice at various ages, namely, 4 
months (young group), 12 months (middle age group), 
18 months (presenium group), and 24 months (aging 
group) were purchased from Suzhou Ai Er Mai Te 
Technology Co., Ltd. (Suzhou, China). All animal 
experiments were conducted according to the Guide for 
the Use and Care of Animals of the National Institutes of 
Health (NIH Publication No. 85-23, revised 1996). All 
animals had free access to standard laboratory rat chow 
and tap water. Until parturition, rats were housed 
individually in a room at constant temperature (24 °C) 
and under a 12-h light–dark cycle. 
 
Cell lines, cell culture, and transfection 
 
The NIH3T3 cell line was purchased from the Basic 
Medical Cell Center of Peking Union Medical College 
(Beijing, China). The NIH3T3 cells were grown in 
Dulbecco’s modified Eagle’s medium (high glucose) 
with 10% calf serum. The cells were cultured at 37°C  
and 5% CO2. Transfection was performed using 
Lipofectamine 3000 reagent (Invitrogen, USA) according 
to the manufacturer’s instructions. Cells were inoculated 
in six-well plates and divided into two groups: pcDNA-
3.1 (no insert) and pcDNA3.1-HSF1. The medium was 
aspirated and replaced with serum-free medium without 
antibiotics 4h before transfection. Lipofectamine 3000 
(3.75 μL) was diluted with 125 μL Opti-MEM and 2.5 μg 
plasmid, 5 μL p3000 were diluted with 125 μL Opti-
MEM® reduced-serum medium (Gibco, Carlsbad, CA, 
USA). The mixtures were incubated for 20 min at room 
temperature and then added to the cells with antibiotic-
free complete medium. Cell lysates were harvested 72h 
after transfection. 
 
siRNA oligos and transfection 
 
Transfection of NIH3T3 cells was performed using 
Lipofectamine RNAiMAX (Thermo Scientific, USA) 
according to the manufacturer’s instructions. Cells were 
inoculated in six-well plates and divided into two 
groups: scramble/HSF1+scramble; si-Omi/HSF1+si-
Omi. HSF1-siRNA5'-GGACACAACCGGAGCCCAA-
3' (25pmol), and RNAiMAX were diluted with Opti-
MEM (#31985; Gibco, Carlsbad, CA, USA). The 
mixtures were incubated for 20 min and then added to 
the cells. The medium was aspirated and replaced with 
Dulbecco’s modified Eagle’s medium (high glucose) 
supplemented with 10% calf serum. The cells were 
harvested 72 h after transfection. 
 
Western blot analysis  
 
Myocardium tissues were harvested for Western Blot 
following standard protocol. Nucleoprotein was extracted 
according to the Nuclear and Cytoplasmic Protein 
Extraction Kit (P0027, Beyotime Institute of 
Biotechnology, Suzhou, China). 50 μg/lane protein or 20 
μg/lane nucleoprotein Proteins were run on 10% SDS-
PAGE, and then electrotransferred onto polyvinylidene 
difluoride membranes. The membranes were incubated 
with the primary antibodies anti-HSF1(#4356; 1:1000; 
Cell Signaling Technology, Danvers, MA, USA), anti-
Omi/HtrA2(#2176; 1:1000; Cell Signaling Technology, 
Danvers, MA, USA), anti-GAPDH(#2118; 1:1000; Cell 
Signaling Technology, Danvers, MA, USA), or anti-
Histone H3 (#4499; 1:1000; Cell Signaling Technology, 
Danvers, MA, USA) overnight at 4°C. After incubation 
with the corresponding secondary antibodies, the 
membrane was developed with a chemiluminescent 
substrate (Bio-Rad), and protein bands were measured 
using the ImageJ software. 
 
Quantitative PCR  
 
The total RNA of was isolated using TRIzol™ reagent 
(Invitrogen; USA) according to the manufacturer’s 
instructions. Total RNA was reverse-transcribed using a 
PrimeScript™ RT Master Mix (#RR036A; Takara), 
gene expression was assessed by real-time PCR using a 
SYBR PrimeScript™ RT-PCR kit (#RR820A; Takara) 
as previously described [12]. Primers for QRT-PCR 
(SYBR) were designed and synthesized as follows: 
Omi-F: 5′-ATCTCCTTTGCCATCCCTTC-3′; Omi-R: 
5′-GGTCAGCATCATCACTCCAA-3′; p16-F: 5′-CGT 
GTCTAGCATGTGGCTTT-3′; P16-R: 5′-GCCTTCGC 
TCAGTTTCTCAT-3′; p53-F: 5′-CGTAAACGCTTCG 
AGATGTTC-3′; P53-R: 5′-GCCCTTCTTGGTCTTCA 
GGT-3′; HSF1-F: 5′-GGCAGTACCTTGGATCAGGA-
3′; HSF1-R: 5′-CAAGTGTGGCTGTGAAGCTG -3′;. 
 
Luciferase activity assay 
 
Luciferase activity assay was performed as previously 
described [12]. The NIH3T3 cells were inoculated in 
96-well plates and then transfected as described in the 
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above methods section using Lipofectamine 3000 
reagent (Invitrogen, USA). The cell lysates were 
harvested 48h after transfection. The Dual-Glo® 
Luciferase Assay System (#E2920; Promega, Madison, 
WI, USA) was used to test the firefly luciferase and 
Renilla luciferase activity using a GloMax® 96-well 
microplate luminometer (Promega, Madison, WI, 
USA) for measurements. Relative luciferase activity 
(RLA) was the ratio of firefly luciferase to Renilla 
luciferase. 
 
Echocardiographic and hemodynamic 
measurements 
 
Left ventricular end-diastolic diameter (LVID(d)), Left 
ventricular posterior wall end-diastolic thickness 
(LVPW(d)), and Left atrioventricular mass (LV mass) 
were measured and recorded on the left heart long axis 
section (Vevo 2100, Visual Sonic, Canada). Eject factor 
(EF) and Fractional shortening (FS) were obtained by 
M-type ultrasound, and all data were measured three 
times and averaged. E-peak and late-filling A were 
evaluated using a mitral valve flow chart. The E/A ratio 
was calculated to reflect left ventricular diastolic 
function. LVID(d), LVPW(d) and LV mass were 
measured without any treatment or exercise load (using 
animal experiment treadmill at a runway speed of 15 
m/min and exercise time of 10 min), and EF, FS, and 
E/A ratio were recorded. 
 
Detection of mouse blood pressure 
 
We used the mouse tail arterial pulse pressure method 
to measure blood pressure; the sensor was set at the 
tail of the mouse, and blood pressure was determined 
by monitoring the blood flow signal while inflating 
and deflating the tail artery and releasing the 
pressure. 
 
Terminal-deoxynucleotidyl transferase mediated 
nick end labeling (TUNEL) staining of mouse hearts 
and determination of Caspase protease activity 
 
The myocardial tissues were perfused with 4% 
paraformaldehyde in PBS, and then embedded in 
paraffin. TUNEL staining (In Situ Cell Death Detection 
Kit, Roche) was performed according to the 
manufacturer's instructions. The percentage of apoptotic 
nuclei in each slide was used to determine the apoptotic 
index. The concentration of the proteins extracted from 
myocardial tissue was determined using the Bradford 
assay. Caspase protease activity was determined with a 
colorimetric assay kit according to the manufacturer’s 
instructions. Briefly, a mixture consisting of 50 μL of the 
2×assay buffer, 30 μL of the sample supernatant, and 10 
μL of ddH2O was prepared. Then, the Ac-DEVD-
AFC/Ac-IETD-AFC/AC-IEHD-AFC/AC-ATAD-AFC 
substrate (10μL) was added to each well of a 96-well 
microplate. The absorbance of each well was then 
measured on a fluorescent microplate reader (Excitation: 
400 nm and Emission: 508 nm). 
 
Chromatin immunoprecipitation (ChIP) assay 
 
ChIP assay (Magna ChIP G Tissue Kit #17-20000; 
Millipore EZ-ChIP, Darmstadt, Germany) was conducted 
as previously reported [12], according to the 
manufacturer's instructions. Mouse myocardial tissues 
was crosslinked with 1% formaldehyde, then sonicated to 
shear chromatin DNA to sizes within the range of 200-
500 bp. The DNA fragments were immunoprecipitated 
with rabbit α-mouse IgG as control and also with 
antibodies specific to HSF1 (#4356; Cell Signaling 
Technology, Danvers, MA, USA). Immunoprecipitation 
was performed overnight at 4°C. The protein/DNA 
complexes and reverse crosslinks of protein/DNA 
complexes to free DNA were eluted, and the 
immunoprecipitated chromatin was amplified using 
primers corresponding to the Omi/HtrA2 promoter. 
Primers were as follows: Omi promoter-F: 5′-
GCTACCGTCGTGCCCTGCTT-3′; Omi promoter-R: 
5′-ATGCCCGAAGGCTCCAGTTT-3′ 
 
Immunohistochemical stain (IHC) 
 
After being embedded in paraffin, all samples of 
thoracic aorta tissue cubes were sectioned into three 4-
mm-thick slices and stained with hematoxylin and eosin 
(HE), Masson’s trichrome and Sirius red stain. 
 
Thoracic aorta tissue samples (1cm3) were fixed with 
para-formaldehyde and embedded in paraffin. 4 μm 
sections were incubated in a dilution of rabbit anti- 
CD31 antibody (ab182981,1:2000, Abcam, USA) 
overnight at 4°C. Immuno-reactivity was detected by 
goat anti-rabbit IgG (zsgb, CHN). After dehydration, all 
sections were observed and photographed using a Nikon 
microscope fitted with a camera (NIKON Corporation, 
JPN). 
 
Antioxidant activity assay and Free radicals 
 
Total antioxidant capacity (T-AOC) (ABTS method), 
SOD activity (WST-1 method) and malondialdehyde 
(MDA) (TBA method were detected according to the 
manufacturer’s instructions by corresponding kits 
(A015-2-1, A001-3, A003-1-2, Nanjing Jiancheng 
Bioengineering Institute, Nanjing, China). The 
absorbance was measured using a microplate reader at 
corresponding wavelength. The T-AOC, SOD activity 
and MDA were calculated with provided formulas 
separately. 
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Assessment of reactive oxygen species (ROS) 
 
The levels of ROS in general was determined by 
reactive oxygen species Assay Kit (E004-1, Nanjing 
Jiancheng Bioengineering Institute). The reaction 
solution was mixed with samples according to the 
manufacturer’s instructions. The cells were washed 
with D-Hank’s and incubated with 
2′,7′dichlorofluorescein diacetate (DCFH-DA) at 37°C 
for 20 min. Then DCF fluorescence distribution of 
cells was detected by fluorospectrophotometer 
analysis at an excitation wavelength of 488 nm and at 
an emission wavelength of 535 nm. 
 
The levels of ROS in mitochondrial was evaluated 
with the same methods after Cells were collected and 
treated according to the manufacturer's instructions 
(Tissue Mitochondria Isolation Kit, Beyotime). 
 
ATP test 
 
ATP Assay Kit (S0026, Beyotime) was measured 
according to the manufacturer’s instructions. The 
reaction solution was mixed with samples at room 
temperature for 5 minutes, and the relative light unit 
(RLU) was measured using a luminometer.  
 
Statistical analysis 
 
All values in the text and figures are expressed as the 
mean ± SEM. All data (except for western blot 
density) were subjected to ANOVA, followed by post 
hoc Bonferroni correction. Western blot densities and 
RT-qPCR were analyzed using the Kruskal-Wallis test 
followed by Dunn’s post hoc test. Probabilities of 0.05 
or less were considered statistically significant. 
 
ACKNOWLEDGMENTS 
 
Huirong Liu and Jing Li contributed to the conception 
of the study; Xinliang Ma designed the work; Dan Liu 
and Linguo Wu performed the experiments; Dan Liu, 
Ye Wu and Xin Wei analyzed the data; Wen Wang, 
Suli Zhang and Ming Yi wrote the manuscript.  
 
CONFLICTS OF INTEREST 
 
The authors declare no conflicts of interest. 
 
FUNDINGS 
 
This research project was supported by grants from 
Beijing Key Laboratory of Cardiovascular Diseases 
Related to Metabolic Disturbance, the Natural 
Sciences Foundation of China grants (81270283, 
81700270). 
REFERENCES 
 
1. Fiechter M, Fuchs TA, Gebhard C, Stehli J, Klaeser B, 
Stähli BE, Manka R, Manes C, Tanner FC, Gaemperli O, 
Kaufmann PA. Age-related normal structural and 
functional ventricular values in cardiac function 
assessed by magnetic resonance. BMC Med Imaging. 
2013; 13:6. 
 https://doi.org/10.1186/1471-2342-13-6 
PMID:23391039  
2. Papp Z, Czuriga D, Balogh L, Balogh Á, Borbély A. How 
cardiomyocytes make the heart old. Curr Pharm 
Biotechnol. 2012; 13:2515–21. 
 https://doi.org/10.2174/1389201011208062515 
PMID:22280426  
3. Zhao T, Huang X, Han L, Wang X, Cheng H, Zhao Y, 
Chen Q, Chen J, Cheng H, Xiao R, Zheng M. Central role 
of mitofusin 2 in autophagosome-lysosome fusion in 
cardiomyocytes. J Biol Chem. 2012; 287:23615–25. 
 https://doi.org/10.1074/jbc.M112.379164 
PMID:22619176  
4. Li H, Wang Y, Wei C, Bai S, Zhao Y, Li H, Wu B, Wang R, 
Wu L, Xu C. Mediation of exogenous hydrogen sulfide 
in recovery of ischemic post-conditioning-induced 
cardioprotection via down-regulating oxidative stress 
and up-regulating PI3K/Akt/GSK-3β pathway in 
isolated aging rat hearts. Cell Biosci. 2015; 5:11. 
 https://doi.org/10.1186/s13578-015-0003-4 
PMID:25789157  
5. Martín-Fernández B, Gredilla R. Mitochondria and 
oxidative stress in heart aging. Age (Dordr). 2016; 
38:225–38. 
 https://doi.org/10.1007/s11357-016-9933-y 
PMID:27449187  
6. Winkler J, Rand ML, Schmugge M, Speer O. Omi/HtrA2 
and XIAP are components of platelet apoptosis 
signalling. Thromb Haemost. 2013; 109:532–39. 
 https://doi.org/10.1160/TH12-06-0404 
PMID:23306356  
7. Xu Z, Chen X, Peng C, Liu E, Li Y, Li C, Niu J. Hypoxia-
inducible factor-1alpha suppressed hepatocellular 
carcinoma cell apoptosis through influencing on 
Omi/HtrA2 expression and its releasing from the 
mitochondrion. Oncol Res. 2012; 20:213–20. 
 https://doi.org/10.3727/096504013X13589503482815 
PMID:23581228  
8. Liu HR, Gao E, Hu A, Tao L, Qu Y, Most P, Koch WJ, 
Christopher TA, Lopez BL, Alnemri ES, Zervos AS, Ma 
XL. Role of Omi/HtrA2 in apoptotic cell death after 
myocardial ischemia and reperfusion. Circulation. 
2005; 111:90–96. 
 https://doi.org/10.1161/01.CIR.0000151613.90994.17 
PMID:15611365  
www.aging-us.com 8993 AGING 
9. Wang K, Zhang J, Liu J, Tian J, Wu Y, Wang X, Quan L, 
Xu H, Wang W, Liu H. Variations in the protein level of 
Omi/HtrA2 in the heart of aged rats may contribute to 
the increased susceptibility of cardiomyocytes to 
ischemia/reperfusion injury and cell death : Omi/HtrA2 
and aged heart injury. Age (Dordr). 2013; 35:733–46. 
 https://doi.org/10.1007/s11357-012-9406-x 
PMID:22535253  
10. Wang K, Yuan Y, Liu X, Lau WB, Zuo L, Wang X, Ma L, 
Jiao K, Shang J, Wang W, Ma X, Liu H. Cardiac specific 
overexpression of mitochondrial Omi/HtrA2 induces 
myocardial apoptosis and cardiac dysfunction. Sci Rep. 
2016; 6:37927. 
 https://doi.org/10.1038/srep37927 PMID:27924873  
11. Liu X, Lei J, Wang K, Ma L, Liu D, Du Y, Wu Y, Zhang S, 
Wang W, Ma X, Liu H. Mitochondrial Omi/HtrA2 
promotes caspase activation through cleavage of HAX-
1 in aging heart. Rejuvenation Res. 2017; 20:183–92. 
 https://doi.org/10.1089/rej.2016.1861 
PMID:27998213  
12. Liu D, Liu X, Wu Y, Wang W, Ma X, Liu H. Cloning and 
transcriptional activity of the mouse Omi/HtrA2 gene 
promoter. Int J Mol Sci. 2016; 17:17. 
 https://doi.org/10.3390/ijms17010119 
PMID:26784188  
13. Urfer SR, Greer K, Wolf NS. Age-related cataract in 
dogs: a biomarker for life span and its relation to body 
size. Age (Dordr). 2011; 33:451–60. 
 https://doi.org/10.1007/s11357-010-9158-4 
PMID:20607428  
14. Zelin E, Freeman BC. Lysine deacetylases regulate the 
heat shock response including the age-associated 
impairment of HSF1. J Mol Biol. 2015; 427:1644–54. 
 https://doi.org/10.1016/j.jmb.2015.02.010 
PMID:25688804  
15. Kwak HB. Aging, exercise, and extracellular matrix in 
the heart. J Exerc Rehabil. 2013; 9:338–47. 
 https://doi.org/10.12965/jer.130049  
PMID:24278882  
16. Liu M, Zhang P, Chen M, Zhang W, Yu L, Yang XC, Fan 
Q. Aging might increase myocardial ischemia / 
reperfusion-induced apoptosis in humans and rats. Age 
(Dordr). 2012; 34:621–32. 
 https://doi.org/10.1007/s11357-011-9259-8 
PMID:21655933  
17. Shih H, Lee B, Lee RJ, Boyle AJ. The aging heart and 
post-infarction left ventricular remodeling. J Am Coll 
Cardiol. 2011; 57:9–17. 
 https://doi.org/10.1016/j.jacc.2010.08.623 
PMID:21185495  
18. Gouspillou G, Sgarioto N, Kapchinsky S, Purves-Smith 
F, Norris B, Pion CH, Barbat-Artigas S, Lemieux F, 
Taivassalo T, Morais JA, Aubertin-Leheudre M,  
Hepple RT. Increased sensitivity to mitochondrial 
permeability transition and myonuclear translocation 
of endonuclease G in atrophied muscle of physically 
active older humans. FASEB J. 2014; 28:1621–33. 
 https://doi.org/10.1096/fj.13-242750  
PMID:24371120  
19. Li H, Zhang C, Sun W, Li L, Wu B, Bai S, Li H, Zhong X, 
Wang R, Wu L, Xu C. Exogenous hydrogen sulfide 
restores cardioprotection of ischemic post-
conditioning via inhibition of mPTP opening in the 
aging cardiomyocytes. Cell Biosci. 2015; 5:43. 
 https://doi.org/10.1186/s13578-015-0035-9 
PMID:26229588  
20. Jones JM, Datta P, Srinivasula SM, Ji W, Gupta S, Zhang 
Z, Davies E, Hajnóczky G, Saunders TL, Van Keuren ML, 
Fernandes-Alnemri T, Meisler MH, Alnemri ES. Loss of 
Omi mitochondrial protease activity causes the 
neuromuscular disorder of mnd2 mutant mice. Nature. 
2003; 425:721–27. 
 https://doi.org/10.1038/nature02052  
PMID:14534547  
21. Martins LM, Morrison A, Klupsch K, Fedele V, Moisoi N, 
Teismann P, Abuin A, Grau E, Geppert M, Livi GP, 
Creasy CL, Martin A, Hargreaves I, et al. 
Neuroprotective role of the Reaper-related serine 
protease HtrA2/Omi revealed by targeted deletion in 
mice. Mol Cell Biol. 2004; 24:9848–62. 
 https://doi.org/10.1128/MCB.24.22.9848-9862.2004 
PMID:15509788  
22. Kang S, Fernandes-Alnemri T, Alnemri ES. A novel role 
for the mitochondrial HTRA2/OMI protease in aging. 
Autophagy. 2013; 9:420–21. 
 https://doi.org/10.4161/auto.22920  
PMID:23242108  
23. Kang S, Louboutin JP, Datta P, Landel CP, Martinez D, 
Zervos AS, Strayer DS, Fernandes-Alnemri T, Alnemri 
ES. Loss of HtrA2/Omi activity in non-neuronal tissues 
of adult mice causes premature aging. Cell Death 
Differ. 2013; 20:259–69. 
 https://doi.org/10.1038/cdd.2012.117  
PMID:22976834  
24. Dayalan Naidu S, Dikovskaya D, Gaurilcikaite E, Knatko 
EV, Healy ZR, Mohan H, Koh G, Laurell A, Ball G, 
Olagnier D, de la Vega L, Ganley IG, Talalay P, Dinkova-
Kostova AT. Transcription factors NRF2 and HSF1 have 
opposing functions in autophagy. Sci Rep. 2017; 
7:11023. 
 https://doi.org/10.1038/s41598-017-11262-5 
PMID:28887499  
25. Ma H, Gong H, Chen Z, Liang Y, Yuan J, Zhang G, Wu J, 
Ye Y, Yang C, Nakai A, Komuro I, Ge J, Zou Y. Association 
of Stat3 with HSF1 plays a critical role in G-CSF-induced 
www.aging-us.com 8994 AGING 
cardio-protection against ischemia/reperfusion injury. J 
Mol Cell Cardiol. 2012; 52:1282–90. 
 https://doi.org/10.1016/j.yjmcc.2012.02.011 
PMID:22426029  
26. Huang CY, Lee FL, Peng SF, Lin KH, Chen RJ, Ho TJ, Tsai 
FJ, Padma VV, Kuo WW, Huang CY. HSF1 
phosphorylation by ERK/GSK3 suppresses RNF126 to 
sustain IGF-IIR expression for hypertension-induced 
cardiomyocyte hypertrophy. J Cell Physiol. 2018; 
233:979–89. 
 https://doi.org/10.1002/jcp.25945  
PMID:28383811  
27. Huang CY, Kuo WW, Yeh YL, Ho TJ, Lin JY, Lin DY, Chu 
CH, Tsai FJ, Tsai CH, Huang CY. ANG II promotes IGF-IIR 
expression and cardiomyocyte apoptosis by inhibiting 
HSF1 via JNK activation and SIRT1 degradation. Cell 
Death Differ. 2014; 21:1262–74. 
 https://doi.org/10.1038/cdd.2014.46  
PMID:24786827  
28. Karvinen S, Silvennoinen M, Vainio P, Sistonen L, Koch 
LG, Britton SL, Kainulainen H. Effects of intrinsic 
aerobic capacity, aging and voluntary running on 
skeletal muscle sirtuins and heat shock proteins. Exp 
Gerontol. 2016; 79:46–54. 
 https://doi.org/10.1016/j.exger.2016.03.015 
PMID:27038700  
29. Ben-Zvi A, Miller EA, Morimoto RI. Collapse of 
proteostasis represents an early molecular event in 
Caenorhabditis elegans aging. Proc Natl Acad Sci USA. 
2009; 106:14914–19. 
 https://doi.org/10.1073/pnas.0902882106 
PMID:19706382  
  
www.aging-us.com 8995 AGING 
SUPPLEMENTARY MATERIALS 
 
 
Supplementary Figures 
 
 
 
Supplementary Figure 1. Identification of the aging mice. mRNA expression of p16 (A) and p53 (B) were increased, protein expression 
of p16, p53 and β-gal (C–F) were increased with aging. Data are represented as mean +/- SEM. n = 6 per group. * p < 0.05 , ** p < 0.01 vs. 4m. 
m=month. 
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Supplementary Figure 2. Systolic blood pressure of the mice. Compared with 4m group, Systolic blood pressure had no significant 
changed with aging. Data are represented as mean +/- SEM. n = 6 per group. m=month. 
 
 
 
Supplementary Figure 3. Thoracic aorta endothelium damaged in aged mice. (A) HE staining of thoracic aorta; (B) Masson 
trichrome stain of thoracic aorta; (C) Sirius red stain of thoracic aorta; (D) immunohistochemistry staining of endothelium marker CD31 of 
thoracic aorta. m=month. n = 6 per group. bar=20μm. 
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Supplementary Figure 4. Antioxidation ability decreased and oxidative stress increased in aged heart. Total antioxidant activity 
(T-AOC) decreased (A), SOD activity decreased with age (B), and malondialdehyde (MDA) increased (C) in aged myocytes. The production of 
ROS in general (D) and mitochondrial in particular (E) was increased in aging heart, ATP was decreased in aging myocardium (F), compared 
with 4 month old mice. Data are represented as mean +/- SEM. n = 6 per group. * p < 0.05 , ** p < 0.01, *** p < 0.001 vs. 4m. m=month. 
 
 
 
Supplementary Figure 5. No correlation between caspase-9 activity and diastolic function. n=32. 
